Myles Helfand and Laura Waters, M.D., FRCP, discuss recently published, clinically noteworthy findings from a trio of venerable HIV cohort studies. First, they review new data from the ATHENA study on non-AIDS events among so-called "HIV controllers." They then move on to recent findings from the START study regarding the link between ART initiation timing and cardiovascular disease risk. Finally, they explore new REPRIEVE data exploring the impact (or lack thereof) of statin use on non-cardiovascular events. ¶ Read (and share!) the full transcript: <a title= "https://www.thebodypro.com/hiv/future-hiv-care-nuances-matter-april-2025" href= "https://www.thebodypro.com/hiv/future-hiv-care-nuances-matter-april-2025" data-outlook-id= "7c0e7783-5daa-4d9e-97b4-191563e0109c">https://www.thebodypro.com/hiv/future-hiv-care-nuances-matter-april-2025</a> ¶ The pod production team: Our senior production manager is Alina Mogollon-Volk; our senior producer is Lizzie Warren; our associate production manager is Maui Voskova; our audio editor is Kim Buikema; and our executive producer is Myles Helfand.

Myles Helfand and Laura Waters, M.D., FRCP, discuss recently published, clinically noteworthy findings from a trio of venerable HIV cohort studies. First, they review new data from the ATHENA study on non-AIDS events among so-called "HIV controllers." They then move on to recent findings from the START study regarding the link between ART initiation timing and cardiovascular disease risk. Finally, they explore new REPRIEVE data exploring the impact (or lack thereof) of statin use on non-cardiovascular events. ¶ Read (and share!) the full transcript: https://www.thebodypro.com/hiv/future-hiv-care-nuances-matter-april-2025 ¶ The pod production team: Our senior production manager is Alina Mogollon-Volk; our senior producer is Lizzie Warren; our associate production manager is Maui Voskova; our audio editor is Kim Buikema; and our executive producer is Myles Helfand.

Myles Helfand and Laura Waters, M.D., FRCP, discuss recently published, clinically noteworthy findings from a trio of venerable HIV cohort studies. First, they review new data from the ATHENA study on non-AIDS events among so-called "HIV controllers." They then move on to recent findings from the START study regarding the link between ART initiation timing and cardiovascular disease risk. Finally, they explore new REPRIEVE data exploring the impact (or lack thereof) of statin use on non-cardiovascular events. ¶ Read (and share!) the full transcript: <a title="https://www.thebodypro.com/hiv/future-hiv-care-nuances-matter-april-2025" href="https://www.thebodypro.com/hiv/future-hiv-care-nuances-matter-april-2025" rel="noopener noreferrer">https://www.thebodypro.com/hiv/future-hiv-care-nuances-matter-april-2025</a> ¶ The pod production team: Our senior production manager is Alina Mogollon-Volk; our senior producer is Lizzie Warren; our associate production manager is Maui Voskova; our audio editor is Kim Buikema; and our executive producer is Myles Helfand.

In HIV Care, the Nuances Matter

Science is restless. It's always seeking, always exploring, always striving to answer new questions and build off the knowledge it has already gained. In HIV, we've spent decades refining our understanding of the virus and its complex web of intersections with our bodies and our societies. Yet we constantly strive to learn more, and to create ever-more-effective means by which we can prevent HIV transmission, treat HIV infection, and improve the length and quality of the lives of people affected by this 40-year pandemic.

In this monthly podcast, HIV and the Future will zoom in on one area within HIV-related science to highlight innovative projects and explain the bigger questions and issues they seek to resolve. Our explorations will include current and upcoming pilot studies or demonstration programs, as well as unsung but important new projects that seek to tackle big issues around HIV prevention, treatment, and care. 

We will interview the scientists and clinicians involved in this innovative work, as well as experts in relevant subfields who can speak to the broader implications of that work for the future of HIV and health care.

Medicine

Health & Fitness

Science is restless. It's always seeking, always exploring, always striving to answer new questions and build off the knowledge it has already gained. In HIV, we've spent decades refining our understanding of the virus and its complex web of intersections with our bodies and our societies. Yet we constantly strive to learn more, and to create ever-more-effective means by which we can prevent HIV transmission, treat HIV infection, and improve the length and quality of the lives of people affected by this 40-year pandemic. In this monthly podcast, HIV and the Future will zoom in on one area within HIV-related science to highlight innovative projects and explain the bigger questions and issues they seek to resolve. Our explorations will include current and upcoming pilot studies or demonstration programs, as well as unsung but important new projects that seek to tackle big issues around HIV prevention, treatment, and care. We will interview the scientists and clinicians involved in this innovative work, as well as experts in relevant subfields who can speak to the broader implications of that work for the future of HIV and health care.

Share In HIV Care, the Nuances Matter

Sign up to save your podcasts

In HIV Care, the Nuances Matter

In HIV Care, the Nuances Matter

More shows like The Future of HIV Care

The Disco, Funky and Soulful House Sessions

The New Yorker Radio Hour

Pod Save America

This Podcast Will Kill You

The Ezra Klein Show

On with Kara Swisher

National HIV Curriculum Podcast